About Us

Our Board of Directors

Dr David Tuch

Chair of the Board

David gained his PhD from MIT and Harvard Medical School working in diffusion-weighted MRI. He served as Global Head of Imaging at Novartis and then as Head of Research Alliances at GE Healthcare, before founding Lightpoint Medical to develop a novel miniaturised gamma ray sensor for surgery for prostate cancer and other conditions. After building the company over 10 years, he recently exited Lightpoint Medical to Telix Pharmaceuticals.

David has supported Lucida Medical since 2021.

 

Read more about David

Dr Antony Rix

CEO and Co-Founder

Antony has spent the last 30 years researching, working and building companies in artificial intelligence, signal processing and software.

His first startup, Psytechnics (acquired 2011 by Netscout) was built on his PhD research, patents and an international standard that he helped secure. He then gained experience on medical devices and large development programmes as Senior Consultant at TTP (acquired by an employee trust in 2021).

Antony has focused on development of AI for cancer imaging since 2018.

Read more about Antony

Professor Evis Sala

Chief Medical Officer and Co-Founder

Evis is a Board Certified radiologist and an expert in cancer imaging, radiology and artificial intelligence in healthcare. She serves as Chair of Radiology at Polyclinico Gemelli in Rome, Italy’s leading cancer hospital.

She was previously Chief of Body Imaging, at Memorial Sloan Kettering Cancer Centre and Professor of Radiology, Weill Cornell Medical College, then Professor of Oncological Imaging at the University of Cambridge and Honorary Consultant Radiologist at Addenbrooke’s Hospital.

Evis has focused on research and clinical applications of AI in cancer imaging since 2018, and co-founded Lucida Medical with Antony Rix in 2019.

 

Read more about Evis

Chief Technology Officer

 

Mark Hinton

A physicist with 30 years of experience in managing complex systems and business processes, Mark has built software teams, delivered phase I-III clinical trial programmes for major pharmaceutical companies and innovative biotech companies, and developed clinical research organisation (CRO) and medical device businesses.

Mark was previously Chief Technology Officer at IAG – Image Analysis Group and Technology Director at Fitch Ratings.

Top

More about Mark

Our Partners